CNTA CENTESSA PHARMACEUTICALS PLC Investments/Divestments 8-K Filing 2023 - Sales Agreement with SVB Securities Centessa Pharmaceuticals plc entered into a Sales Agreement with SVB Securities for an at-the-market offering program, allowing the company to issue and sell up to $125 million of its American Depositary Shares.Get access to all SEC 8-K filings of the CENTESSA PHARMACEUTICALS PLC